PALISADE BIO, INC.
Developing oral precision therapies for inflammatory and fibrotic intestinal diseases like colitis.
PALI | NDAQ
Overview
Corporate Details
- ISIN(s):
- US6963894026 (+1 more)
- LEI:
- Country:
- United States of America
- Address:
- 7750 EL CAMINO REAL, SUITE 5200, 92009 CARLSBAD
- Website:
- https://palisadebio.com/
- Sector:
- Manufacturing
- Industry:
- Manufacture of pharmaceuticals, medicinal chemical and botanical products
Description
Palisade Bio, Inc. is a clinical-stage biopharmaceutical company dedicated to advancing next-generation precision therapies. The company focuses on developing novel oral therapeutics for patients with immune, inflammatory, and fibrotic diseases, particularly those related to the integrity of the intestinal barrier. Palisade Bio utilizes advanced machine learning to identify patient populations with specific biomarkers, such as elevated PDE4 activity, to enhance the efficacy of its treatments. Its lead program, PALI-2108, is being developed for the treatment of ulcerative colitis.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| No filings match the current criteria. | |||||
Automate Your Workflow. Get a real-time feed of all PALISADE BIO, INC. filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for PALISADE BIO, INC.
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for PALISADE BIO, INC. via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
